Molecular profiling of ulcerative colitis-associated neoplastic progression

Daniel W. Colliver, Nigel P.S. Crawford, Maurice R. Eichenberger, Wolfgang Zacharius, Robert E. Petras, Arnold J. Stromberg, Susan Galandiuk

Research output: Contribution to journalArticlepeer-review

30 Scopus citations


Fundamental differences exist between ulcerative colitis (UC)-associated and sporadic forms of colorectal cancer, including preexisting inflammation, type of dysplasia, and timing of molecular events in carcinogenesis. Transcriptional alterations that occur in UC-associated neoplasia in the progression from normal mucosa through dysplastic epithelium to invasive cancer have not been described. We used Affymetrix U95Av2 microarrays to assess differential gene expression in the neoplastic progression of UC tissue from the colonic mucosa of individuals with benign UC, UC-dysplasia-associated lesions or masses, and UC adenocarcinoma. By correlating transcript alterations across tissue types using a mixed statistical model, we identified 699 genes exhibiting altered expression with dysplasia development. A different expression profile was observed in progression to adenocarcinoma with 392 transcripts exhibiting differential expression. There were 224 transcripts common to both dysplasia and adenocarcinoma. Most of the differentially expressed genes described herein were not previously known to play a role in neoplastic progression in UC, including transcripts affecting cell proliferation and apoptosis, signal transduction and signaling, and DNA repair. The altered expression of five transcripts was confirmed by quantitative real-time reverse-transcription polymerase chain reaction. Based on comparisons with previous studies on sporadic colorectal carcinoma, several similarities were found. There were, however, important differences that suggest that different molecular events may occur in the development of UC-associated neoplasia. Several of these genes demonstrated similar changes in dysplastic and cancerous tissue and may be involved in early cancer formation. Identification of these genes as potential clinical biomarkers may lead to improved early disease diagnosis.

Original languageEnglish
Pages (from-to)1-10
Number of pages10
JournalExperimental and Molecular Pathology
Issue number1
StatePublished - Feb 2006

Bibliographical note

Funding Information:
Supported in part by the James and Emmeline Ferguson Research Fund.


  • Carcinoma
  • Dysplasia
  • Gene expression
  • Inflammatory bowel disease
  • Ulcerative colitis

ASJC Scopus subject areas

  • Pathology and Forensic Medicine
  • Molecular Biology
  • Clinical Biochemistry


Dive into the research topics of 'Molecular profiling of ulcerative colitis-associated neoplastic progression'. Together they form a unique fingerprint.

Cite this